PKMYT1 inhibitor (RP-6306), modulates the cell cycle progression and induces PANoptosis in pancreatic cancer cells, thereby inhibiting tumor growth and proliferation both in vitro and in vivo. Here, PKMYT1 is linked to neoplasm.